Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
The management of hypertension is going to reach a new dimension. As per a recent review in the Lancet, scientists say that an annual two injection intake may be very helpful in improving the management of high blood pressure. This new method of treating hypertension may benefit millions of patients who find it difficult to take daily medications and cannot easily control their blood pressure.Hypertension is also referred to as high blood pressure, and more than a billion people in the world have the disease. It is the most prominent risk factor of heart disease, stroke, and kidney failure, among other severe health challenges. Although there are numerous oral medications that are effective, compliance is one of the biggest problems.
A significant number of patients forget to take a pill on a daily basis, discontinue medication because of side effects, or have trouble with complicated treatment programs. Consequently, a significant percentage of people did not manage to control their blood pressure, which puts them at risk of health problems in the long run.It is in this case where long acting blood pressure therapy might come in handy.
The Lancet review indicates new treatments that involve injectable drugs in the form of long acting drugs that reduce blood pressure in the long run. Patients would be able to get two injections once a year, and they would be able to control their blood pressure on a regular basis over months.
Such injections can possibly act by attacking the mechanism in the regulation of blood pressure, including hormones to control salt balance and vascular tone. Long-acting injections can stabilize blood pressure fluctuations and enhance protection of the heart and the entire system due to the ability to provide stable levels of medication in the body.
Two Injections A Year Could Transform Hypertension Care: Lancet Reviewhttps://t.co/l2ku0n6aO0
Tanushka Dutta (@TanushkaDutta) February 15, 2026
The possible advantages of the biannual injections in hypertension include:
Source: World Health Federation
Such a new model of hypertension care can be of particular benefit to:
Although encouraging, researchers mention that additional large scale clinical studies are required to attest to safety and effectiveness over a long period of time. The price, affordability and its compatibility with the current healthcare systems will also be significant in the process of establishing how mainstream this treatment will be.
Overall, the Lancet review is also an indication that there is an exciting change in the treatment strategy of hypertension. Biannual injections would transform the way that high blood pressure is treated in the world, and it would no longer be necessary to take pills every day, but rather to use long acting and patient friendly injections. With the ongoing research, this breakthrough could present new hope for improved blood pressure management, and the risk of cardiovascular disease in the global population will become lower.
Disclaimer: Dear readers, this article provides general information and advice only. It is not at all professional medical advice. Therefore, always consult your doctor or a healthcare specialist for more information. TheHealthSite.com does not claim responsibility for this information.